Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/1995
05/31/1995EP0576420B1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
05/31/1995CN1028655C NF-1616-904 oxide of pyrazine and medicine composition contained this compound
05/31/1995CA2136936A1 Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives
05/30/1995US5420287 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
05/30/1995US5420141 Capable of binding to neurotensin receptor
05/30/1995US5420109 Cytokine restraining agents
05/26/1995WO1995014085A2 A method for detection of alterations in the dna mismatch repair pathway
05/26/1995WO1995014028A2 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995WO1995014017A1 Non-peptide tachykinin receptor antagonists
05/26/1995WO1995013826A1 Preventive and remedy for allergic disease
05/26/1995WO1995013801A1 Fatty acid delivery system
05/26/1995WO1995013767A1 Osteogenic product and process
05/26/1995WO1995013697A1 Hepatoblasts and method of isolating same
05/26/1995WO1995001168A3 Pharmaceutical preparations that contain an active substance with modified amidine groups
05/26/1995CA2176819A1 A method for detection of alterations in the dna mismatch repair pathway
05/26/1995CA2176808A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995CA2176735A1 Non-peptide tachykinin receptor antagonists
05/26/1995CA2136661A1 Use of 1-{4-[4-aryl (or heteroaryl)-1-peperazinyl]-butyl}-1 -h-azole derivatives in the preparation of drugs used for treating gastric secretion disorders
05/24/1995EP0654471A1 Pyridine derivatives, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments having therapeutic or preventative value, and process for preparing the same
05/24/1995EP0654272A1 Alimentary canal cell activator
05/23/1995US5418241 Antiserotonin agents
05/23/1995US5418224 Antibiotic
05/23/1995CA1335624C Synthetic aluminum silicate preparation
05/18/1995WO1995013365A1 Generation of high titers of recombinant aav vectors
05/18/1995WO1995013297A2 Improved immunogenic compositions against human gastrin 17
05/18/1995WO1995013296A1 Receptor specific atrial natriuretic peptides
05/18/1995WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995WO1995013277A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995WO1995013262A1 Substituted phenyl compounds
05/18/1995WO1995013090A1 Improved interferon polymer conjugates
05/18/1995WO1995013086A1 Cytokine restraining agents
05/18/1995WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995CA2176363A1 Substituted phenyl compounds
05/18/1995CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995CA2175897A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/17/1995EP0652949A1 Non-native liver generation in an animal with impaired native liver function by cell implantation
05/17/1995EP0652879A1 1-azaadamantane derivatives as 5-ht agonists or antagonists
05/17/1995EP0652873A1 Benzodiazepine derivatives
05/17/1995EP0652872A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds
05/17/1995EP0652871A1 Benzodiazepine derivatives
05/17/1995EP0652868A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF
05/17/1995EP0652767A1 Treatment of human lactation failure
05/17/1995EP0652759A1 Ibuprofen-antacid combinations
05/17/1995EP0652757A1 Sugar-free dry mix cellulose ether compositions as bulk laxatives
05/17/1995EP0652756A1 Pharmaceutical compositions and use of dilinoleoylphosphatidylcholine (dlpc) for treatment and prevention of cirrhosis and fibrosis in the liver
05/17/1995EP0652753A1 Treatment of dentoalveolar infections with taurolidine and/or taurultam
05/17/1995EP0652751A1 Injection and injection kit containing omeprazole and its analogs.
05/17/1995CN1028429C Method for preparing of substd. Thieno (2,3-B)(1,5) benzodiazepine derivatives
05/17/1995CN1028408C New 1,4-diazepine derivatives having antiulcer activity
05/16/1995US5416221 Carbazolone derivatives
05/16/1995US5416194 Extracted from horseshoe crab
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995CA1335592C Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds
05/11/1995WO1995012611A1 Endothelin receptor antagonists
05/11/1995WO1995012590A1 Preparation of omeprazole and lansoprazole and intermediates useful therein
05/11/1995WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications
05/11/1995WO1995012405A1 Method and composition for treatment of patients having decompensated liver disease
05/11/1995WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2173875A1 Endothelin receptor antagonists
05/10/1995EP0652015A2 A sustained release composition comprising a multivalent cation cross-linked algenate combined with a polyacrylic acid
05/10/1995EP0652013A1 Use of bovine colostrum as a preparation for liver
05/10/1995EP0651807A1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
05/10/1995EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors
05/10/1995EP0651652A1 Treatment for sensitive teeth
05/10/1995EP0651639A1 Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
05/10/1995EP0510154B1 9-HALOGEN-11(Beta)-HYDROXY PROSTAGLANDIN DERIVATIVE, PROCESS FOR PRODUCING IT AND ITS USE AS A MEDICAMENT
05/10/1995CN1102347A Specific hemorrhoid wine
05/10/1995CN1102342A Radix sophorae flavescentis, large-flowered skullcap root and coptis root tablet
05/09/1995CA1335501C Methods for preparing sucralfate and aa1-10001
05/04/1995WO1995011904A1 Novel a1 adenosine receptor agonists and antiagonists
05/04/1995WO1995011889A1 Thiazole derivative and drug containing the same
05/04/1995WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995WO1995011699A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
05/04/1995WO1995011693A1 Hemoregulatory peptides
05/04/1995WO1994028132A3 Opioid receptors: compositions and methods
05/04/1995CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/03/1995EP0650961A1 Substituted heterocyclic carboxylic acid amides, their preparation, and their use as medicaments
05/03/1995EP0650355A1 Medicaments for the treatment of visceral pain and migraine
05/03/1995EP0650331A1 Food products containing benzimidazole
05/03/1995EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives
05/03/1995CN1102124A Method for treating hepatitis B carriers with minimal disease
05/03/1995CA2134866A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
05/02/1995US5412145 P2'-modified hydroxamic acid collagenase inhibitors
05/02/1995US5411993 Anti-inflammatory, stable aqueous preparation comprising azulene sodium sulfonate and polyhydric alcohol
05/02/1995US5411971 N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions
05/02/1995US5411943 Hepatoma treatment with somatostatin analogs
04/1995
04/27/1995WO1995011259A1 Platelet-derived growth factor analogues
04/27/1995WO1995011236A1 New chemopreventive compounds and a preparation method and use thereof
04/27/1995WO1995011041A1 Method for improving utilisation of nutrients by ruminant or ruminant-like animals
04/27/1995WO1995011032A1 Senna dosage form
04/27/1995WO1995011024A1 Picosulphate dosage form
04/27/1995WO1995011021A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents
04/27/1995WO1995011014A1 Amidino derivatives useful as nitric oxide synthase inhibitors
04/27/1995WO1995002406A3 Use of benzothiophenes and benzofurans for the treatment of inflammatory bowel disease and inflammation assay method
04/27/1995DE4437725A1 Verwendung von Saccharomyces-Hefen für die Herstellung eines Arzneimittels gegen Kryptosporidiose Use of Saccharomyces yeasts for the manufacture of a medicament against cryptosporidiosis
04/27/1995CA2170735A1 Amidino derivatives useful as nitric oxide synthase inhibitors
04/26/1995EP0649906A1 Nucleotide sequences coding for a protein with urease activity
04/26/1995EP0649414A1 Opioid diarylmethylpiperazines and piperidines
1 ... 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 ... 1258